Start with the organization model
Use the venture capital classification as a starting point, then verify what the organization actually does today.
Explore the ecosystem
Venture Capital Firms
Professional investment firms that raise capital from limited partners and deploy it into startups. Typically write checks from $500K to $50M+ across defined stages.
Continue exploring
Choose the next useful view
Compare organization typesReturn to the complete organization taxonomy and choose another kind of institution.ExploreExplore by placeUse city and country guides to understand the surrounding ecosystem.ExploreExplore by sectorStart with a market and follow its related organizations and programs.Explore
Evaluate venture capital firms in context
Verify current activity
Confirm current services, investment activity, programs, eligibility, and terms from recent primary sources.
Keep useful candidates
Open supported Superscout profiles when available, then save or follow the organizations relevant to your work.
Venture Capital Firms directory
Browse organizations currently classified under this type. Open profiles are linked when Superscout has a supported internal profile.
22,896 venture capital firms
Venture CapitalCAVU
Investing in better-for-you consumer brands.
Venture CapitalInvesting in family-owned businesses in Brazil.
Venture CapitalInvesting in innovative startups for long-term growth.
Venture CapitalInvesting in the future of blockchain and digital assets.
Venture CapitalEvidence-based investing in healthcare and life sciences.
Venture CapitalInvesting in next-generation technology leaders.
Venture CapitalInvesting in innovative healthcare solutions.
Venture CapitalInvesting in design-led technology startups.
Venture CapitalIGNITION POINT, Inc.
Catalyst for innovation and technology.
Venture CapitalLeading asset management firm in Brazil.
Venture CapitalInvesting in early-stage technology companies.
Venture CapitalInvesting in the next generation of founders.
Venture CapitalInvestment management specializing in clean energy and infrastructure.
Venture Capital阿里资本
Venture CapitalInvesting in extraordinary entrepreneurs.
Venture CapitalUK's largest provider of tax-efficient investments.
Venture CapitalInvesting in technology for a better future.
Venture CapitalAccelerating Science-for-Impact innovation.
Venture CapitalBRI
Investing in innovative technologies for a sustainable future.
Venture CapitalInvesting in deep tech for a better future.
Venture CapitalAvenir Group
Avenir Group is an investment group that focuses on integrating traditional finance with digital assets. Originating from Mr. Li Lin’s family office, it aims to drive innovation and build financial ecosystems through investment, incubation, and operational frameworks. Avenir Group is recognized as Asia's largest institutional Bitcoin ETF holder and is committed to establishing a global hub for capital mobility and strategic partnerships. The group specializes in financial innovation, particularly in cryptocurrency asset management, employing diverse multi-asset and multi-strategy approaches. Its investment activities include quantitative trading, public markets, private equity, and digital asset sectors. Avenir Group also invests in emerging technologies, supporting companies that drive blockchain and AI integration. The company emphasizes compliance, sustainability, and long-term growth, maintaining a global presence with operations in the United States, Europe, and Asia.
Venture CapitalBrace Pharma
Brace Pharma Capital is a strategic investment firm based in Atlanta, GA, and serves as the U.S. affiliate of EMS S/A, Brazil's largest pharmaceutical company. The firm collaborates with high net worth biotech investors to fund innovative therapies aimed at addressing diseases with significant unmet medical needs. Brace Pharma focuses on late-stage clinical programs with commercialization potential within 3-5 years, allocating approximately 80% of its portfolio to clinical-phase projects. The firm emphasizes investments in breakthrough therapies for life-threatening diseases, particularly in areas such as cancer immunotherapies and viral therapies. Brace Pharma partners closely with its portfolio companies to enhance therapy development and market success. Led by industry veterans, including Chairman Carlos Sanchez and Director Raymond F. Schinazi, the firm has made 29 investments and achieved 8 portfolio exits, targeting clinical-stage biotechs. Notable investments include Turnstone Biologics and Avidity Biosciences, among others.
Venture CapitalInvesting in early-stage healthcare and technology disruptors.
Venture CapitalSalim Group Inc.
Superscout Pro
Turn venture capital research into a working shortlist.
- Save supported organization profiles
- Keep private evaluation notes
- Compare related organizations and programs
- Monitor relevant ecosystem changes
$99$249 first year
Superscout ProIllustrative
Scout profile Structured activity
Memo drafted
Submitted
Following
Superscout documents the venture capital firms shown on this page independently from canonical records and linked sources. Missing facts stay missing.
Sources and known limits
A reviewed date is not available for this page.
No public source link is attached to this page yet.
Terms, dates, and eligibility can change. Confirm time-sensitive details with the original source.
Superscout is not affiliated with, endorsed by, or acting on behalf of the organizations documented here.